Ifm Investors Pty LTD Sarepta Therapeutics, Inc. Transaction History

Ifm Investors Pty LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 16, 2021	SELL	$69.38 - $86.75 $600,553 - $750,908	-8,656 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$72.25 - $168.95 $128,171 - $299,717	1,774 Added 25.78%	8,656 $645,000
Q4 2020 Jan 13, 2021	BUY	$125.56 - $178.74 $116,896 - $166,406	931 Added 15.64%	6,882 $1.17 Million
Q3 2020 Oct 16, 2020	BUY	$127.12 - $172.34 $66,865 - $90,650	526 Added 9.7%	5,951 $836,000
Q2 2020 Jul 13, 2020	SELL	$93.0 - $171.7 $176,142 - $325,199	-1,894 Reduced 25.88%	5,425 $870,000
Q1 2020 Apr 09, 2020	BUY	$82.38 - $131.64 $12,439 - $19,877	151 Added 2.11%	7,319 $721,000
Q4 2019 Jan 13, 2020	SELL	$76.53 - $135.58 $31,683 - $56,130	-414 Reduced 5.46%	7,168 $925,000
Q3 2019 Nov 01, 2019	BUY	$72.81 - $156.91 $552,045 - $1.19 Million	7,582 New	7,582 $571,000

536

87.4M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.31B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Ifm Investors Pty LTD with notifications on news.